Elevance Health (ELV, Financial) has reported impressive first-quarter revenues, totaling $48.8 billion. This figure significantly exceeds analysts' expectations, which were set at $46.25 billion.
The company's primary focus is on enhancing the healthcare experience through various innovative approaches. These include offering personalized support and implementing real-time digital solutions. Additionally, Elevance Health is committed to a comprehensive health model that aims to improve patient outcomes while also reducing costs.
Through its brand, Carelon, and other parts of the organization, Elevance Health is working to solidify its position as a trusted partner in health over an individual’s lifetime. The company is committed to advancing health beyond traditional healthcare methods, reflecting its ongoing dedication to bettering human health on a global scale.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 19 analysts, the average target price for Elevance Health Inc (ELV, Financial) is $493.87 with a high estimate of $585.00 and a low estimate of $428.00. The average target implies an upside of 21.44% from the current price of $406.69. More detailed estimate data can be found on the Elevance Health Inc (ELV) Forecast page.
Based on the consensus recommendation from 24 brokerage firms, Elevance Health Inc's (ELV, Financial) average brokerage recommendation is currently 2.1, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Elevance Health Inc (ELV, Financial) in one year is $622.26, suggesting a upside of 53.01% from the current price of $406.69. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Elevance Health Inc (ELV) Summary page.
